Register information Patent

DE file number : 60 2009 018 299.4 (Status: pending/in force, Query started: May 3, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2009 018 299.4
96EP file numberEAKZ11 00 9919.9
97EP publication numberEPN2431741
54Designation/titleTIVerfahren zur Bestimmung aktiver Inhaltsstoffe in Arzneimittelvorstufen-Peg-Protein-Konjugaten mit freisetzbaren Peg-Reagentien (in-vitro-Depegylierung)
51IPC main classICM
(ICMV)
G01N 33/542 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
G01N 33/58 (2006.01), G01N 33/68 (2006.01), G01N 33/86 (2006.01)
22DE application dateDATOct 20, 2009
96EP application dateEATOct 20, 2009
43Date of first publicationOTMar 21, 2012
Date of publication of grantPETAug 21, 2013
71/73Applicant/ownerINHNektar Therapeutics, San Francisco, Calif., US; Takeda Pharmaceutical Company Limited, Osaka-shi, JP
72InventorINCulbertson, Sean M., Gurley AL 35758, US; Weber, Alfred, 1210 Vienna, AT; Anderle, Heinz, 3400 Klosterneuburg, AT; Zappe, Harold, Harvest 35749, US; Turecek, Peter, 3400 Klosterneuburg, AT; Rottensteiner, Hanspeter, 1020 Vienna, AT; Bossard, Mary J., Madison AL 35758, US; Varadi, Katalin, 1230 Vienna, AT; Zhang, Ping, Millbrae CA 94030, US; Fang, Zhihao, MadisonAL 35758, US; Schrenk, Gerald, 1220 Vienna, AT
74RepresentativeVTRBird & Bird LLP, 80333 München, DE
Address for service Bird & Bird LLP, 80333 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
10725708 P
Oct 21, 2008
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
24263409 P
Sep 15, 2009
Due dateFT
FG
Oct 31, 2025
Annual fee for the 17th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002431741
Searchable text: EP000002431741
Original document: EP000002431741B1
Searchable text: EP000002431741B1
43Date of first publicationEVTMar 21, 2012
Date of the first transfer into DPMAregisterEREGTMay 3, 2012
Date of the (most recent) update in DPMAregisterREGTSep 27, 2024
(Show all update days)(Hide all update days)
  • Sep 27, 2024
    • Due date: changed
  • Sep 28, 2023; Sep 29, 2022; Nov 11, 2021; Nov 4, 2021; Sep 30, 2021; Sep 22, 2020; Sep 26, 2019; Sep 25, 2018; Oct 26, 2017; Sep 27, 2017; Sep 15, 2017; Aug 31, 2017; Jul 25, 2017; Nov 8, 2016; Nov 10, 2015; Oct 27, 2015; Nov 19, 2014; Sep 4, 2014; Jul 31, 2014; Feb 20, 2014; Nov 16, 2013; Nov 7, 2013; Oct 17, 2013; Sep 4, 2013; Sep 3, 2013; Aug 31, 2013; Aug 23, 2013; Aug 22, 2013; Feb 16, 2013
    • Historical data not available for this/these date(s)
  • May 3, 2012
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Mar 21, 2012  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA May 3, 2012 May 3, 2012 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 21, 2013  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Oct 17, 2013 Oct 17, 2013 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 22, 2014 Sep 4, 2014 Details anzeigen
6 New applicant/owner details New applicant/owner details Jul 24, 2017 Aug 31, 2017 Details anzeigen
7 New applicant/owner details New applicant/owner details Sep 14, 2017 Oct 26, 2017 Details anzeigen
8 New applicant/owner details New applicant/owner details Nov 3, 2021 Dec 9, 2021 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 21, 2012
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 3, 2012
Issue numberHN18
YearPJ2012
Publication dateVTMay 3, 2012
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 21, 2013
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTOct 17, 2013
Issue numberHN42
YearPJ2013
Publication dateVTOct 17, 2013
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 22, 2014
Issue numberHN36
YearPJ2014
Publication dateVTSep 4, 2014
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 24, 2017
Issue numberHN35
YearPJ2017
Publication dateVTAug 31, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHBaxalta GmbH, Glattpark, Opfikon, CH; Baxalta Inc., Bannockburn, Ill., US; Nektar Therapeutics, San Francisco, Calif., US
71/73Previous applicant/ownerINHFBaxter Healthcare SA, Glattpark, Opfikon, CH, Baxter International Inc., Deerfield, Ill., US, Nektar Therapeutics, San Francisco, Calif., US
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 14, 2017
Issue numberHN43
YearPJ2017
Publication dateVTOct 26, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHBaxalta GmbH, Glattpark, Opfikon, CH; Baxalta Incorporated, Bannockburn, Ill., US; Nektar Therapeutics, San Francisco, Calif., US
71/73Previous applicant/ownerINHFBaxalta GmbH, Glattpark, Opfikon, CH, Baxalta Inc., Bannockburn, Ill., US, Nektar Therapeutics, San Francisco, Calif., US
View procedures New applicant/owner details (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 3, 2021
Issue numberHN49
YearPJ2021
Publication dateVTDec 9, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHNektar Therapeutics, San Francisco, Calif., US; Takeda Pharmaceutical Company Limited, Osaka-shi, JP
71/73Previous applicant/ownerINHFBaxalta GmbH, Glattpark, Opfikon, CH, Baxalta Incorporated, Bannockburn, Ill., US, Nektar Therapeutics, San Francisco, Calif., US
Date of update of the procedureREGTNov 11, 2021